Literature DB >> 11238214

Antibody responses to Campylobacter infections determined by an enzyme-linked immunosorbent assay: 2-year follow-up study of 210 patients.

M A Strid1, J Engberg, L B Larsen, K Begtrup, K Mølbak, K A Krogfelt.   

Abstract

An enzyme-linked immunosorbent assay (ELISA) was adapted to measure immunoglobulin G (IgG), IgM, and IgA classes of human serum antibody to Campylobacter jejuni and Campylobacter coli. Heat-stable antigen, a combination of C. jejuni serotype O:1,44 and O:53 in the ratio 1:1, was used as a coating antigen in the ELISA test. A total of 631 sera from 210 patients with verified Campylobacter enteritis were examined at various intervals after infection, and a control group of 164 sera were tested to determine the cut-off for negative results. With a 90th percentile of specificity, IgG, IgM, and IgA showed a sensitivity of 71, 60, and 80%, respectively. By combining all three antibody classes, the sensitivity was 92% within 35 days after infection, whereas within 90 days after infection, a combined sensitivity of 90% was found (IgG 68%, IgM 52%, and IgA 76%). At follow-up of the patients, IgG antibodies were elevated 4.5 months after infection but exhibited a large degree of variation in antibody decay profiles. IgA and IgM antibodies were elevated during the acute phase of infection (up to 2 months from onset of infection). The antibody response did not depend on Campylobacter species or C. jejuni serotype, with the important exception of response to C. jejuni O:19, the serotype most frequently associated with Guillain-Barré syndrome. All of the patients infected with this serotype had higher levels of both IgM (P = 0.006) and IgA (P = 0.06) compared with other C. jejuni and C. coli serotypes.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11238214      PMCID: PMC96055          DOI: 10.1128/CDLI.8.2.314-319.2001

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  18 in total

1.  Campylobacter etiology in human gastroenteritis demonstrated by antibodies to acid extract antigen.

Authors:  H I Rautelin; T U Kosunen
Journal:  J Clin Microbiol       Date:  1987-10       Impact factor: 5.948

2.  Prevalence of Campylobacter, Arcobacter, Helicobacter, and Sutterella spp. in human fecal samples as estimated by a reevaluation of isolation methods for Campylobacters.

Authors:  J Engberg; S L On; C S Harrington; P Gerner-Smidt
Journal:  J Clin Microbiol       Date:  2000-01       Impact factor: 5.948

3.  Diffusion-in-gel enzyme-linked immunosorbent assay for routine detection of IgG and IgM antibodies to Campylobacter jejuni.

Authors:  A Svedhem; H Gunnarsson; B Kaijser
Journal:  J Infect Dis       Date:  1983-07       Impact factor: 5.226

4.  Human serum antibody response to Campylobacter jejuni infection as measured in an enzyme-linked immunosorbent assay.

Authors:  M J Blaser; D J Duncan
Journal:  Infect Immun       Date:  1984-05       Impact factor: 3.441

5.  Enzyme-linked immunosorbent assay (ELISA) for antibodies against Campylobacter jejuni, and its clinical application.

Authors:  M Walder; A Forsgren
Journal:  Acta Pathol Microbiol Immunol Scand B       Date:  1982-12

6.  Serum antibodies in Campylobacter enteritis.

Authors:  J Kaldor; H Pritchard; A Serpell; W Metcalf
Journal:  J Clin Microbiol       Date:  1983-07       Impact factor: 5.948

7.  Serotyping of Campylobacter jejuni and Campylobacter coli on the basis of thermostable antigens.

Authors:  J L Penner; J N Hennessy; R V Congi
Journal:  Eur J Clin Microbiol       Date:  1983-08       Impact factor: 3.267

8.  Detection of serum antibody response in patients infected with one strain of Campylobacter jejuni with a DIG-ELISA method.

Authors:  K Melby; T Tønjum; F Skjørten
Journal:  NIPH Ann       Date:  1986-12

9.  Serologic study of two clusters of infection due to Campylobacter jejuni.

Authors:  M J Blaser; D J Duncan; M T Osterholm; G R Istre; W L Wang
Journal:  J Infect Dis       Date:  1983-05       Impact factor: 5.226

10.  Campylobacter jejuni strains from patients with Guillain-Barré syndrome.

Authors:  B M Allos; F T Lippy; A Carlsen; R G Washburn; M J Blaser
Journal:  Emerg Infect Dis       Date:  1998 Apr-Jun       Impact factor: 6.883

View more
  22 in total

1.  Identification of immunogenic and virulence-associated Campylobacter jejuni proteins.

Authors:  Lene N Nielsen; Thomas A Luijkx; Christina S Vegge; Christina Kofoed Johnsen; Piet Nuijten; Brendan W Wren; Hanne Ingmer; Karen A Krogfelt
Journal:  Clin Vaccine Immunol       Date:  2011-12-07

2.  Comparison of rheumatological and gastrointestinal symptoms after infection with Campylobacter jejuni/coli and enterotoxigenic Escherichia coli.

Authors:  H Locht; K A Krogfelt
Journal:  Ann Rheum Dis       Date:  2002-05       Impact factor: 19.103

3.  Kinetics of the human antibody response against Salmonella enterica Serovars Enteritidis and Typhimurium determined by lipopolysaccharide enzyme-linked immunosorbent assay.

Authors:  Mette A Strid; Tine Dalby; Kåre Mølbak; Karen A Krogfelt
Journal:  Clin Vaccine Immunol       Date:  2007-02-28

4.  Assessment of the duration of protection in Campylobacter jejuni experimental infection in humans.

Authors:  David R Tribble; Shahida Baqar; Daniel A Scott; Michael L Oplinger; Fernando Trespalacios; David Rollins; Richard I Walker; John D Clements; Steven Walz; Paul Gibbs; Edward F Burg; Anthony P Moran; Lisa Applebee; A Louis Bourgeois
Journal:  Infect Immun       Date:  2010-01-19       Impact factor: 3.441

5.  Is the Campylobacter jejuni secretory protein Cj0069 a suitable antigen for serodiagnostics?

Authors:  J Corso; R Lugert; U Groß; A E Zautner
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2011-03

6.  Recrudescent Campylobacter jejuni infection in an immunocompetent adult following experimental infection with a well-characterized organism.

Authors:  Shahida Baqar; David R Tribble; Marya Carmolli; Katrin Sadigh; Frederic Poly; Chad Porter; Catherine J Larsson; Kristen K Pierce; Patricia Guerry; Michael Darsley; Beth Kirkpatrick
Journal:  Clin Vaccine Immunol       Date:  2009-11-18

Review 7.  Host-pathogen interactions in Campylobacter infections: the host perspective.

Authors:  Riny Janssen; Karen A Krogfelt; Shaun A Cawthraw; Wilfrid van Pelt; Jaap A Wagenaar; Robert J Owen
Journal:  Clin Microbiol Rev       Date:  2008-07       Impact factor: 26.132

8.  Reactive arthritis and serum levels of mannose binding lectin -- lack of association.

Authors:  H Locht; M Christiansen; I Laursen
Journal:  Clin Exp Immunol       Date:  2003-01       Impact factor: 4.330

Review 9.  Global Distribution of Campylobacter jejuni Penner Serotypes: A Systematic Review.

Authors:  Brian L Pike; Patricia Guerry; Frédéric Poly
Journal:  PLoS One       Date:  2013-06-27       Impact factor: 3.240

10.  Epidemiological and serological investigation of a waterborne Campylobacter jejuni outbreak in a Danish town.

Authors:  K Gaardbo Kuhn; G Falkenhorst; H-D Emborg; T Ceper; M Torpdahl; K A Krogfelt; S Ethelberg; K Mølbak
Journal:  Epidemiol Infect       Date:  2016-12-01       Impact factor: 4.434

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.